Get the Stockscreener App
1.14
2.75%
0.05
Neuronetics Inc stock is traded at $1.14, with a volume of 150.28K.
It is up +2.75% in the last 24 hours and up +31.78% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.09
Open:
$1.1
24h Volume:
150.28K
Relative Volume:
0.37
Market Cap:
$33.94M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-1.0088
EPS:
-1.13
Net Cash Flow:
$-39.26M
1W Performance:
+10.89%
1M Performance:
+31.78%
6M Performance:
-70.60%
1Y Performance:
-20.00%
1-Day Range:
$1.05
$1.1399
1-Week Range:
$0.9807
$1.1399
52-Week Range:
$0.664
$5.0699
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
Neuronetics Inc Stock (STIM) Latest News
A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St
Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World
Neuronetics to Unveil Q3 2024 Financial Results - MSN
Neuronetics extends Madryn registration rights period By Investing.com - Investing.com South Africa
Neuronetics extends Madryn registration rights period - Investing.com India
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - The Manila Times
Transcranial Magnetic Stimulator Market Projected To Witness Substantial Growth, 2024-2031:Nexstim Plc, - EIN News
Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com
NeuroStar TMS data presented at AACAP meeting By Investing.com - Investing.com Australia
NeuroStar TMS data presented at AACAP meeting - Investing.com
NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - The Manila Times
Transcranial Magnetic Stimulator Market will generate new - openPR
Neuronetics executive sells shares worth over $1,200 By Investing.com - Investing.com South Africa
Neuronetics executive sells shares worth over $1,200 - Investing.com India
Neuronetics EVP Stephen Furlong sells shares worth over $1,100 - Investing.com India
Neuronetics faces potential Nasdaq delisting - Investing.com India
Neuronetics faces potential Nasdaq delisting By Investing.com - Investing.com UK
Neuronetics Moves to Acquire Greenbrook in Stock Deal - TipRanks
Neuronetics Set to Acquire Greenbrook TMS - TipRanks
Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - StockTitan
Neuronetics Outlines Greenbrook Acquisition Prospects and Risks - TipRanks
SEC Form DEFA14A filed by Neuronetics Inc. - Quantisnow
Neuronetics Expands TMS Access for Adolescents with Depression - MyChesCo
Neuronetics GAAP EPS of -$0.27 beats by $0.04, revenue of $17.42M beats by $0.3M - MSN
STIM stock rated a Mkt perform by William Blair - Knox Daily
Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook - Investing.com
In the Green: Neuronetics Inc (STIM) Closes at 0.75, Up/Down -3.85 from Previous Day - The Dwinnex
Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook By Investing.com - Investing.com South Africa
Neuronetics Inc (STIM) deserves closer scrutiny - US Post News
Neuronetics Inc [STIM] Shares Fall -6.18 % on Wednesday - Knox Daily
Neuronetics Inc (STIM) Stock: A Year of Declines and Increases - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Neuronetics Inc (STIM) - The Dwinnex
Stoke Therapeutics Inc (STOK) expanding its growth trajectory ahead - SETE News
Neuronetics announces HCSC expanded access to TMS for adolescents - TipRanks
In the Green: NeuroSense Therapeutics Ltd (NRSN) Closes at 1.25, Up/Down -3.50 from Previous Day - The Dwinnex
Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents - Yahoo Finance
NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World
NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule - PR Newswire
How did Stoke Therapeutics Inc (STOK) fare last session? - US Post News
Logos Global Management LP Invests $14.19 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK) - MarketBeat
Recent Insider Activity Could Benefit Stoke Therapeutics Inc (STOK) - Knox Daily
Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.7% - MarketBeat
STIM Stock Likely to Gain From Updated TMS Coverage - Zacks Investment Research
First Eagle Investment Management LLC Purchases 260,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo
Neuronetics Enhances NeuroStar Therapy with New Features - MSN
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - StockTitan
Acadian Asset Management LLC Purchases 62,628 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World
Greenbrook TMS announces acquisition by Neuronetics - Investing.com Canada
STIM’s Stock Swings: Riding the 2023 Wave of Ups and Downs - The InvestChronicle
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuronetics Inc Stock (STIM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | EVP, GC, CCO and CS |
Oct 08 '24 |
Sale |
0.82 |
1,541 |
1,264 |
402,792 |
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):